Sex and depot differences in ex vivo adipose tissue fatty acid storage and glycerol-3-phosphate acyltransferase activity

Abstract

Morgan-Bathke M, Chen L, Oberschneider E, Harteneck D, Jensen MD. Sex and depot differences in ex vivo adipose tissue fatty acid storage and glycerol-3-phosphate acyltransferase activity. Am J Physiol Endocrinol Metab 308: E830 -E846, 2015. First published March 3, 2015 doi:10.1152/ajpendo.00424.2014.-Adipose tissue fatty acid storage varies according to sex, adipose tissue depot, and degree of fat gain. However, the mechanism(s) for these variations is not completely understood. We examined whether differences in adipose tissue glycerol-3-phosphate acyltransferase (GPAT) might play a role in these variations. We optimized an enzyme activity assay for total GPAT and GPAT1 activity in human adipose tissue and measured GPAT activity. Omental and subcutaneous adipose tissue was collected from obese and nonobese adults for measures of GPAT and GPAT1 activities, ex vivo palmitate storage, acyl-CoA synthetase (ACS) and diacylglycerol-acyltransferase (DGAT) activities, and CD36 protein. Total GPAT and GPAT1 activities decreased as a function of adipocyte size in both omental (r ϭ Ϫ0.71, P ϭ 0.003) and subcutaneous (r ϭ Ϫ0.58, P ϭ 0.04) fat. The relative contribution of GPAT1 to total GPAT activity increased as a function of adipocyte size, accounting for up to 60% of GPAT activity in those with the largest adipocytes. We found strong, positive correlations between ACS, GPAT, and DGAT activities for both sexes and depots (r values 0.58 -0.91) and between these storage factors and palmitate storage rates into TAG (r values 0.55-0.90). We conclude that: 1) total GPAT activity decreases as a function of adipocyte size; 2) GPAT1 can account for over half of adipose GPAT activity in hypertrophic obesity; and 3) ACS, GPAT, and DGAT are coordinately regulated. omental fat; subcutaneous fat; fat distribution; glycerol-3-phosphate acyltransferase 1 BODY FAT DISTRIBUTION PLAYS an important role in the development of the comorbidities associated with obesity. In general, adults with greater amounts of visceral fat have more risk for chronic disease than those with a lesser proportion of visceral fat (14). Although regional balances of fatty acids (uptake vs. release) should determine whether one depot expands at the expense of another, interindividual differences in regional lipolysis (8,13,24) and meal fat storage (21, 26, 31) do not appear to explain differences in body fat distribution. We found that direct free fatty acid (FFA) storage rates in subcutaneous fat are greater in women than men and that the sex-specific variations in direct FFA storage into adipocyte triacylglycerol (TAG) are consistent with body fat distribution patterns (16,18,28). On average, the protein content (CD36 and fatty acid transport protein 1) and enzyme activity [acyl-

New Nordic Diet–Induced Weight Loss Is Accompanied by Changes in Metabolism and AMPK Signaling in Adipose Tissue

“…The size of adipocytes has been speculated to have specific influence on adipocyte proteins associated to the lipid droplets and the plasma membrane, independently of sample or lipid weight (51)(52)(53). In the present study, the metabolic protein expression was measured relative to total protein content in the samples.…”

Sorting out adipocyte precursors and their role in physiology and disease

“…Adding to the complexity, individual depots may contain adipocytes that arise through distinct lineages (Sanchez-Gurmaches and Guertin 2014). Molecular and cellular studies indicate that anatomically distinct depots are also functionally distinct and express differing molecular programs (Macotela et al 2012;Wu et al 2012;Lee et al 2013;Morgan-Bathke et al 2015). As a result, the simple designation of white adipocytes as "subcutaneous" or "visceral" is likely too simplistic.…”

The expanding problem of adipose depot remodeling and postnatal adipocyte progenitor recruitment

“…Whole adipose depot transplantation experiments in mice indicate that factors intrinsic to these depots determine their effect on glucose homeostasis (Tran et al, 2008). A number of studies collectively demonstrate that anatomically distinct adipocytes, in isolation, are functionally unique, differing in their ability to undergo lipolysis, lipogenesis, and activate thermogenic programs (Lee et al, 2013; Macotela et al, 2012; Morgan-Bathke et al, 2015; Wu et al, 2012). Thus, an emerging hypothesis is that anatomically distinct WAT depots likely represent distinct “mini-organs.” A better understanding of how these distinct depots arise and expand during development may lead to therapeutic strategies to alter body fat distribution.…”